Adjuvant Chemotherapy with Traditional Chinese Herbal Granules Versus Placebo in Resected Non-Small Cell Lung Cancer: Updated Survival Analysis of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial | Synapse
March 3, 2026Open Access
Adjuvant Chemotherapy with Traditional Chinese Herbal Granules Versus Placebo in Resected Non-Small Cell Lung Cancer: Updated Survival Analysis of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Key Points
Survival analysis indicates improved outcomes with adjuvant chemotherapy using traditional Chinese herbal granules.
Key evidence reveals a significant difference in survival rates between the treatment and placebo groups.
This multicenter, randomized, double-blind, placebo-controlled trial assessed the effectiveness of herbal granules in lung cancer patients.
Findings may enable further exploration of traditional remedies in modern treatments, highlighting potential benefits.